Does Dr. RONALD GLINSKI have financial conflicts of interest?

Dr. RONALD GLINSKI (MD) has received a total of $3,992 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $3,992 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RONALD GLINSKI?

According to CMS Open Payments data, Dr. RONALD GLINSKI received funding from PROCEPT BIOROBOTICS CORPORATION ($1,001), BOSTON SCIENTIFIC CORPORATION ($839), and COLOPLAST ($429).

Does Dr. RONALD GLINSKI receive research grants or speaking fees?

Dr. RONALD GLINSKI has received $3,992 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RONALD GLINSKI

MDReal-Time Hydrated

Specialty: Urology, Urogynecology and Reconstructive Pelvic Surgery

Practice Location: FLORENCE, SC 29506

NPI Number: 1801836747

LIFETIME INDUSTRY VALUE

$3,992

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. GLINSKI is a verified Urology, Urogynecology and Reconstructive Pelvic Surgery practitioner based in FLORENCE, SC.

Between 2021 and 2024, Dr. GLINSKI had an overall industry promotional and research financial footprint of $3,992 as recorded in the federal CMS Open Payments database.

$3,992 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. GLINSKI's primary funding source is PROCEPT BIOROBOTICS CORPORATION, which accounts for $1,001 (representing 25.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

PROCEPT BIOROBOTICS CORPORATION

Rank 1

$1,001

25.1%

BOSTON SCIENTIFIC CORPORATION

Rank 2

$839

21%

COLOPLAST

Rank 3

$429

10.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.